| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 807.12B | 737.38B | 642.81B | 631.51B | 607.66B | 592.05B |
| Gross Profit | 94.48B | 81.67B | 68.73B | 71.80B | 67.47B | 62.26B |
| EBITDA | 65.19B | 56.18B | 47.23B | 52.25B | 50.82B | 46.55B |
| Net Income | 23.46B | 19.25B | 14.56B | 19.01B | 17.25B | 16.66B |
Balance Sheet | ||||||
| Total Assets | 784.22B | 770.84B | 689.52B | 703.89B | 685.27B | 672.25B |
| Cash, Cash Equivalents and Short-Term Investments | 77.86B | 85.12B | 83.47B | 109.75B | 108.49B | 103.05B |
| Total Debt | 118.00B | 125.95B | 47.34B | 50.15B | 50.17B | 47.73B |
| Total Liabilities | 348.82B | 347.26B | 253.94B | 254.16B | 251.74B | 249.61B |
| Stockholders Equity | 409.03B | 397.00B | 430.38B | 444.85B | 429.89B | 419.26B |
Cash Flow | ||||||
| Free Cash Flow | 12.81B | 14.62B | 25.04B | 14.34B | 16.14B | 3.23B |
| Operating Cash Flow | 50.85B | 52.75B | 48.44B | 39.27B | 45.53B | 38.69B |
| Investing Cash Flow | -27.02B | -69.51B | -24.51B | -29.59B | -31.79B | -27.97B |
| Financing Cash Flow | -23.13B | 18.59B | -49.65B | -8.17B | -7.88B | -10.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥116.15B | 35.08 | ― | 3.57% | 3.00% | 5.43% | |
73 Outperform | ¥19.26B | 6.47 | ― | 2.46% | 0.21% | 0.95% | |
72 Outperform | ¥227.49B | 3.64 | 4.72% | 1.66% | 5.50% | -26.63% | |
70 Outperform | ¥26.60B | 10.21 | ― | 2.82% | 2.47% | 2.85% | |
64 Neutral | ¥378.48B | 11.50 | 5.53% | 4.35% | 22.07% | 86.12% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
54 Neutral | ¥606.16B | 5.81 | 7.44% | 2.10% | 5.58% | 114.23% |